Matches in Wikidata for { <http://www.wikidata.org/entity/Q66394357> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q66394357 description "clinical trial" @default.
- Q66394357 description "ensayu clínicu" @default.
- Q66394357 description "klinisch onderzoek" @default.
- Q66394357 description "клінічне випробування" @default.
- Q66394357 description "կլինիկական փորձարկում" @default.
- Q66394357 name "Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression" @default.
- Q66394357 name "Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression" @default.
- Q66394357 type Item @default.
- Q66394357 label "Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression" @default.
- Q66394357 label "Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression" @default.
- Q66394357 prefLabel "Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression" @default.
- Q66394357 prefLabel "Ibrutinib in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia With Risk of Disease Progression" @default.
- Q66394357 P1050 Q66394357-53DB89B8-9C30-4E36-BC0C-A6AF466A966F @default.
- Q66394357 P1132 Q66394357-B7F40104-8B6C-4AA5-91ED-AF53D1587C9F @default.
- Q66394357 P1476 Q66394357-92E1AC26-758B-4731-8EBB-2BAFE160134F @default.
- Q66394357 P17 Q66394357-5D966D85-7D48-45B9-AE3F-3259AABE823A @default.
- Q66394357 P1813 Q66394357-3FA9A9FB-51F2-4B61-A1D1-96BD3A639092 @default.
- Q66394357 P2899 Q66394357-826B944A-76A6-4EFF-9885-A3AF54473AF6 @default.
- Q66394357 P3098 Q66394357-C54C5FD1-DD3A-45B2-9132-925BE37BB2F6 @default.
- Q66394357 P31 Q66394357-F19D79E0-5B5C-4501-B458-01F6031150AA @default.
- Q66394357 P580 Q66394357-5538990D-7699-4373-8092-96173293D8F6 @default.
- Q66394357 P582 Q66394357-50A788D5-8A08-446D-B5A0-D49D48A65881 @default.
- Q66394357 P6099 Q66394357-031400E0-5BC8-4D3A-A5BF-49E82F72AB51 @default.
- Q66394357 P8363 Q66394357-905A7430-FAEC-4231-94F1-5E9BB36A1432 @default.
- Q66394357 P1050 Q29496 @default.
- Q66394357 P1132 "+515" @default.
- Q66394357 P1476 "A Placebo-Controlled, Double-Blind, Randomized, Multicenter, Three Arm Phase III Trial to Compare the Efficacy and Safety of Ibrutinib vs. Placebo in Previously Untreated Binet Stage A Chronic Lymphocytic Leukemia Patients With Risk of Early Disease Progression" @default.
- Q66394357 P17 Q183 @default.
- Q66394357 P1813 "CLL12" @default.
- Q66394357 P2899 "+18" @default.
- Q66394357 P3098 "NCT02863718" @default.
- Q66394357 P31 Q30612 @default.
- Q66394357 P580 "2014-04-30T00:00:00Z" @default.
- Q66394357 P582 "2019-03-07T00:00:00Z" @default.
- Q66394357 P6099 Q42824827 @default.
- Q66394357 P8363 Q78089383 @default.